Zika Virus Vaccine (DNA-Based) from Mexico
Recombinant DNA plasmid Zika vaccine expressing prM-E proteins for neutralizing antibodies. HTS 3002.49.00 for biotechnologically obtained 'other' vaccines. Investigational multi-dose regimen.
Duty Rate — Mexico → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Submit Investigational New Drug (IND) documentation
• Classify as finished vaccine product, not gene therapy
• Ensure biotech modification records match heading scope